Structure Therapeutics Inc. financial data

Symbol
GPCR on Nasdaq
Location
611 Gateway Blvd Suite 223, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.98K % -25.6%
Debt-to-equity 5.78 % +31.4%
Return On Equity -26.1 % -59.2%
Return On Assets -24.7 % -57.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 182M shares +5.97%
Common Stock, Shares, Outstanding 182M shares +5.98%
Entity Public Float 1.95B USD +289%
Common Stock, Value, Issued 18K USD +5.88%
Weighted Average Number of Shares Outstanding, Basic 175M shares +2.24%
Weighted Average Number of Shares Outstanding, Diluted 175M shares +2.24%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 190M USD +99.3%
General and Administrative Expense 57.6M USD +23%
Operating Income (Loss) -248M USD -74.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -210M USD -89.9%
Income Tax Expense (Benefit) 481K USD +17.4%
Net Income (Loss) Attributable to Parent -211M USD -90.6%
Earnings Per Share, Basic -1 USD/shares -68.1%
Earnings Per Share, Diluted -0.37 USD/shares -85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD -40.2%
Cash, Cash Equivalents, and Short-term Investments 799M USD -12.7%
Assets, Current 814M USD -11.9%
Property, Plant and Equipment, Net 4.68M USD +25.2%
Operating Lease, Right-of-Use Asset 6.86M USD +71.2%
Other Assets, Noncurrent 6.6M USD +262%
Assets 832M USD -10.8%
Accounts Payable, Current 17.8M USD +111%
Employee-related Liabilities, Current 8.55M USD +39.9%
Liabilities, Current 57.5M USD +72.1%
Operating Lease, Liability, Noncurrent 4.29M USD +60.4%
Other Liabilities, Noncurrent 325K USD +5.18%
Liabilities 62.1M USD +70.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 825K USD -70.9%
Retained Earnings (Accumulated Deficit) -503M USD -72%
Stockholders' Equity Attributable to Parent 770M USD -14.1%
Liabilities and Equity 832M USD -10.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52.2M USD -53.3%
Net Cash Provided by (Used in) Financing Activities 809K USD +15.2%
Net Cash Provided by (Used in) Investing Activities 34M USD +2300%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 182M shares +5.98%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17.4M USD +45.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 103M USD -40.2%
Deferred Tax Assets, Valuation Allowance 68.2M USD +32.3%
Deferred Tax Assets, Gross 69.1M USD +30.9%
Operating Lease, Liability 7.09M USD +61.7%
Depreciation 274K USD +23.4%
Payments to Acquire Property, Plant, and Equipment 314K USD +93.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -213M USD -98%
Lessee, Operating Lease, Liability, to be Paid 7.92M USD +65.2%
Property, Plant and Equipment, Gross 5.11M USD +32.1%
Operating Lease, Liability, Current 2.8M USD +63.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.72M USD -11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.22M USD +62.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 834K USD +103%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.28M USD +234%
Deferred Tax Assets, Operating Loss Carryforwards 26.2M USD -10.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 7.95M USD +806%
Lessee, Operating Lease, Liability, to be Paid, Year Four 938K USD
Operating Lease, Payments 600K USD +100%
Additional Paid in Capital 1.27B USD +7.24%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 913K USD -25.4%
Share-based Payment Arrangement, Expense 26.8M USD +77.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%